Biocure Technology Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	0.06	0.32	0.34	0.67	0.57
Operating Expenses	0.06	0.32	1.05	0.67	1.73
Operating Income	-0.06	-0.32	-1.05	-0.67	-1.73
Interest Expense	-0.01	-0.01	-0.01	-0	-0.06
Earnings From Equity Investments	-	-	-0.18	-	-
Currency Exchange Gain (Loss)	-	-	-	-0	-0
Other Non Operating Income (Expenses)	-0.03	0.06	0.05	-0.02	-0.07
EBT Excluding Unusual Items	-0.1	-0.26	-1.19	-0.7	-1.87
Gain (Loss) on Sale of Investments	-	-	-0.74	-	-
Other Unusual Items	-0	-	0.43	0.3	-
Pretax Income	-0.1	-0.26	-1.49	-0.4	-1.87
Earnings From Continuing Operations	-0.1	-0.26	-1.49	-0.4	-1.87
Earnings From Discontinued Operations	-	-	-0.35	-1.11	0.72
Net Income to Company	-0.1	-0.26	-1.84	-1.52	-1.15
Minority Interest in Earnings	-	-	0.03	0.06	0.02
Net Income	-0.1	-0.26	-1.81	-1.45	-1.13
Net Income to Common	-0.1	-0.26	-1.81	-1.45	-1.13
Shares Outstanding (Basic)	16	10	10	12	11
Shares Outstanding (Diluted)	16	10	10	12	11
Shares Change (YoY)	50.69%	1.23%	-13.15%	3.76%	4.98%
EPS (Basic)	-0.01	-0.03	-0.18	-0.12	-0.10
EPS (Diluted)	-0.01	-0.03	-0.18	-0.12	-0.10
Free Cash Flow	-0.08	0.01	-0.22	-0.83	-1.08
Free Cash Flow Per Share	-0.01	0.00	-0.02	-0.07	-0.10
EBITDA	-	-	-	-0.67	-1.67
D&A For EBITDA	-	-	-	0.01	0.06
EBIT	-0.06	-0.32	-1.05	-0.67	-1.73